Comparison of the Effectiveness of Cognitive-Behavioral Therapy and Acceptance and Commitment Therapy on Quality of Life in Asthma Patients
Keywords:
Cognitive-Behavioral Therapy, Acceptance and Commitment Therapy, Quality of Life, AsthmaAbstract
Objective: The aim of the present study was to compare the effectiveness of Cognitive-Behavioral Therapy (CBT) and Acceptance and Commitment Therapy (ACT) on the quality of life in asthma patients.
Methods and Materials: The research design was experimental with a pretest-posttest and control group. The statistical population consisted of all asthma patients who visited treatment centers in Tehran between April and July 2024 for the management and treatment of their condition. A total of 90 individuals were selected through convenience sampling and randomly assigned to three groups: CBT group (30 individuals), ACT group (30 individuals), and a control group (30 individuals). The data collection tool was the World Health Organization Quality of Life Questionnaire. The intervention treatments were administered in 8 weekly sessions, each lasting 90 minutes, while the control group did not receive any specific treatment during this period. The data were analyzed using Multivariate Analysis of Covariance (MANCOVA).
Findings: The results indicated that both CBT and ACT were effective in improving the quality of life of asthma patients (P < 0.05), and there was no significant difference between the effectiveness of these two therapeutic approaches (P > 0.05).
Conclusion: The findings potentially provide important practical implications for professionals and therapists regarding the effectiveness of the therapeutic methods used in improving asthma outcomes.
Downloads
Downloads
Additional Files
Published
Submitted
Revised
Accepted
Issue
Section
License
Copyright (c) 2024 Seyed Soroush Ghaffari (Author); Mohammad Taqi Badeleh Shamooshaki (Corresponding Author); Leila Sadat Azizi Ziabari, Javanshir Asadi (Author)
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.